Amrap AT 5 mg/50 mg Tablet
By Amrap AT
Rx
10 Tablet in a Strip

Composition
Amlodipine(5mg) + Atenolol(50mg)

Manufacturer - Rapross Pharmaceuticals Pvt Ltd
IInd Floor, Garg Plaza, 5 Community Centre, Sector-8, Rohini, Delhi-110085

Expires on or after
July, 2025

liver
When it comes to the safety of using Amrap AT 5 mg/50 mg Tablet, especially for individuals with liver disease, caution is advised. Patients with liver issues should approach the use of Amrap AT 5 mg/50 mg Tablet carefully as a dose adjustment may be necessary. It is recommended to consult your doctor before starting this medication if you have a liver condition. Typically, Amrap AT 5 mg/50 mg Tablet is initiated at a lower dose for individuals with liver disease and then gradually increased while closely monitoring the patient's response.

kidney
Amrap AT 5 mg/50 mg Tablet should be used carefully in patients with kidney problems. Dosage adjustment might be necessary. Consult your doctor. Regular blood pressure monitoring is advised for proper dose adjustment.

alcohol
It is unsafe to drink alcohol while taking Amrap AT 5 mg/50 mg Tablet. Avoid alcohol consumption with this medication.

driving
Amrap AT 5 mg/50 mg Tablet may cause side effects like dizziness, headaches, nausea, or tiredness, which can impair focus and reaction time while driving. It is advisable to be cautious when driving after taking this medication.

pregnancy
Amrap AT 5 mg/50 mg Tablet should not be used during pregnancy due to risk to the baby. Consult your doctor before use.

breastfeeding
Amrap AT 5 mg/50 mg Tablet is probably unsafe to use during breastfeeding. Limited data indicates possible transfer of the drug into breastmilk, potentially harmful to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹233
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025